Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Roger A. Jeffs, PhD$1B
Market Cap • 18/04/20242004
(há 20 anos)
2018
(6 years ago)
NASDAQ
Listagem
Morrisville
Sede • North Carolina63
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
LQDASó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.